Literature DB >> 24434371

Echinacea purpurea (L.) Moench modulates human T-cell cytokine response.

Fabiana N Fonseca1, Genovefa Papanicolaou2, Hong Lin3, Clara B S Lau4, Edward J Kennelly5, Barrie R Cassileth1, Susanna Cunningham-Rundles6.   

Abstract

The study objective was to evaluate the composition of a neutral and weakly acidic water-soluble extract from Echinacea purpurea (L.) Moench (EchNWA) previously shown to modify murine influenza infection, and to assess immunomodulatory effects on human T-cells. EchNWA extract from fresh aerial parts was extracted with water, ethanolic precipitation, and size-exclusion chromatography. The chemical profile of EchNWA was characterized by chromatography (size-exclusion, HPLC, GC-MS), and small molecule fingerprint analysis performed by HPLC-PDA. Jurkat T-cells at high and low cell density were pretreated or not with doses of EchNWA, followed by activation with phorbol 12-myristate 13-acetate plus ionomycin (PMA+I). Interleukin-2 (IL-2) and interferon gamma (IFNg) cytokine secretions were measured by multi-cytokine luminex technology. Results showed that EchNWA contains 80% polysaccharides, predominantly a 10kDa entity; phenolic compounds, cynarin, cichoric and caftaric acids, but no detectable alkylamides. Cytokine production required stimulation and was lower after PMA+I activation in high-density compared to low-density conditions. EchNWA mediated a strong dose-dependent enhancement of high-density T-cell production of IL-2 and IFNg response to PMA+I. EchNWA alone did not stimulate T-cells. EchNWA enhanced mean fluorescence intensity of IL-2 in Jurkat T-cells activated by PMA+1 or ionomycin alone. Conversely EchNWA mediated modest but significant suppression of IFNg response and reduced the percentage of CD25+ T-cells under low-density conditions. Conclusions are that EchNWA polysaccharides, but not phenolic compounds have dose-related adjuvant effects on human T-cell cytokine responses characterized by enhancing and suppressive effects that are regulated by T-cell density.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytokine response; Echinacea; Human T-cell density; Immune modulation; Neutral and weakly acidic water-soluble extract; Polysaccharides and phenolic compounds; Small molecule fingerprint-analysis

Mesh:

Substances:

Year:  2014        PMID: 24434371      PMCID: PMC4140398          DOI: 10.1016/j.intimp.2013.12.019

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  55 in total

Review 1.  Treatment of the common cold with echinacea: a structured review.

Authors:  Thomas J Caruso; Jack M Gwaltney
Journal:  Clin Infect Dis       Date:  2005-02-18       Impact factor: 9.079

2.  Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea.

Authors:  B Luettig; C Steinmüller; G E Gifford; H Wagner; M L Lohmann-Matthes
Journal:  J Natl Cancer Inst       Date:  1989-05-03       Impact factor: 13.506

3.  Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans.

Authors:  Karin Woelkart; Christoph Koidl; Andrea Grisold; J David Gangemi; Ronald B Turner; Egon Marth; Rudolf Bauer
Journal:  J Clin Pharmacol       Date:  2005-06       Impact factor: 3.126

4.  In vitro and in vivo immune stimulating effects of a new standardized Echinacea angustifolia root extract (Polinacea).

Authors:  P Morazzoni; A Cristoni; F Di Pierro; C Avanzini; D Ravarino; S Stornello; M Zucca; T Musso
Journal:  Fitoterapia       Date:  2005-07       Impact factor: 2.882

5.  Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and Candida albicans.

Authors:  J Roesler; C Steinmüller; A Kiderlen; A Emmendörffer; H Wagner; M L Lohmann-Matthes
Journal:  Int J Immunopharmacol       Date:  1991

6.  Miniaturization of three carbohydrate analyses using a microsample plate reader.

Authors:  J D Fox; J F Robyt
Journal:  Anal Biochem       Date:  1991-05-15       Impact factor: 3.365

7.  Antiviral activity of characterized extracts from echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-I).

Authors:  S E Binns; J Hudson; S Merali; J T Arnason
Journal:  Planta Med       Date:  2002-09       Impact factor: 3.352

8.  Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes.

Authors:  C Steinmüller; J Roesler; E Gröttrup; G Franke; H Wagner; M L Lohmann-Matthes
Journal:  Int J Immunopharmacol       Date:  1993-07

9.  Stimulatory effect of Echinacea purpurea extract on the trafficking activity of mouse dendritic cells: revealed by genomic and proteomic analyses.

Authors:  Shu-Yi Yin; Wen-Hsin Wang; Bi-Xue Wang; Kandan Aravindaram; Pei-Ing Hwang; Han-Ming Wu; Ning-Sun Yang
Journal:  BMC Genomics       Date:  2010-11-01       Impact factor: 3.969

10.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  7 in total

1.  Polycaprolactone Thin-Film Micro- and Nanoporous Cell-Encapsulation Devices.

Authors:  Crystal E Nyitray; Ryan Chang; Gaetano Faleo; Kevin D Lance; Daniel A Bernards; Qizhi Tang; Tejal A Desai
Journal:  ACS Nano       Date:  2015-05-14       Impact factor: 15.881

2.  Ethanolic Echinacea purpurea Extracts Contain a Mixture of Cytokine-Suppressive and Cytokine-Inducing Compounds, Including Some That Originate from Endophytic Bacteria.

Authors:  Daniel A Todd; Travis V Gulledge; Emily R Britton; Martina Oberhofer; Martha Leyte-Lugo; Ashley N Moody; Tatsiana Shymanovich; Laura F Grubbs; Monika Juzumaite; Tyler N Graf; Nicholas H Oberlies; Stanley H Faeth; Scott M Laster; Nadja B Cech
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

3.  A C-banded karyotype of mitotic chromosomes in diploid purple coneflower (Echinacea purpurea L.).

Authors:  Weizhen Jiang; Qingling Li; Xiaolu Chen; Yi Ren; Rong Chen; Hong Wu; Yuesheng Yang
Journal:  Hereditas       Date:  2016-11-22       Impact factor: 3.271

Review 4.  Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common Colds.

Authors:  Mariangela Rondanelli; Alessandra Miccono; Silvia Lamburghini; Ilaria Avanzato; Antonella Riva; Pietro Allegrini; Milena Anna Faliva; Gabriella Peroni; Mara Nichetti; Simone Perna
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-29       Impact factor: 2.629

5.  Proliferative activity of a blend of Echinacea angustifolia and Echinacea purpurea root extracts in human vein epithelial, HeLa, and QBC-939 cell lines, but not in Beas-2b cell lines.

Authors:  Simon Angelo Cichello; Qian Yao; Xiao Qiong He
Journal:  J Tradit Complement Med       Date:  2015-03-11

Review 6.  Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea.

Authors:  Michele Catanzaro; Emanuela Corsini; Michela Rosini; Marco Racchi; Cristina Lanni
Journal:  Molecules       Date:  2018-10-26       Impact factor: 4.411

7.  A systematic review on the effects of Echinacea supplementation on cytokine levels: Is there a role in COVID-19?

Authors:  Monique Aucoin; Valentina Cardozo; Meagan D McLaren; Anna Garber; Daniella Remy; Joy Baker; Adam Gratton; Mohammed Ali Kala; Sasha Monteiro; Cara Warder; Alessandra Perciballi; Kieran Cooley
Journal:  Metabol Open       Date:  2021-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.